Interview with CEO Nils Brünner and CEO Ole Thastrup (2cureX)

BioStock has interviewed CEO Nils Brünner, Scandion Oncology, and CEO Ole Thastrup, 2cureX, about the Eurostars project on antiestrogen resistance.

The full interview is freely available here: https://www.biostock.se/2020/06/scandion-oncology-och-2curex-erhaller-bidrag-fran-eurostars/

 

Co-funded by the Horizon 2020 programme of the European Union
Co-funded by the COSME programme of the European Union